Streptomyces albus G serine beta-lactamase. Probing of the catalytic mechanism via molecular modelling of mutant enzymes. 1992

J Lamotte-Brasseur, and F Jacob-Dubuisson, and G Dive, and J M Frère, and J M Ghuysen
Centre d'Ingénierie des Protéines, Université de Liège, Sart tilman, Belgium.

In previous studies, several amino acids of the active site of class A beta-lactamases have been modified by site-directed mutagenesis. On the basis of the catalytic mechanism proposed for the Streptomyces albus G beta-lactamase [Lamotte-Brasseur, Dive, Dideberg, Charlier, Frère & Ghuysen (1991) Biochem. J. 279, 213-221], the influence that these mutations exert on the hydrogen-bonding network of the active site has been analysed by molecular mechanics. The results satisfactorily explain the effects of the mutations on the kinetic parameters of the enzyme's activity towards a set of substrates. The present study also shows that, upon binding a properly structured beta-lactam compound, the impaired cavity of a mutant enzyme can readopt a functional hydrogen-bonding-network configuration.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.

Related Publications

J Lamotte-Brasseur, and F Jacob-Dubuisson, and G Dive, and J M Frère, and J M Ghuysen
August 1991, The Biochemical journal,
J Lamotte-Brasseur, and F Jacob-Dubuisson, and G Dive, and J M Frère, and J M Ghuysen
October 1991, The Biochemical journal,
J Lamotte-Brasseur, and F Jacob-Dubuisson, and G Dive, and J M Frère, and J M Ghuysen
July 1987, European journal of biochemistry,
J Lamotte-Brasseur, and F Jacob-Dubuisson, and G Dive, and J M Frère, and J M Ghuysen
August 1987, The Biochemical journal,
J Lamotte-Brasseur, and F Jacob-Dubuisson, and G Dive, and J M Frère, and J M Ghuysen
January 1986, Gene,
J Lamotte-Brasseur, and F Jacob-Dubuisson, and G Dive, and J M Frère, and J M Ghuysen
January 1981, The Biochemical journal,
J Lamotte-Brasseur, and F Jacob-Dubuisson, and G Dive, and J M Frère, and J M Ghuysen
June 1987, The Biochemical journal,
J Lamotte-Brasseur, and F Jacob-Dubuisson, and G Dive, and J M Frère, and J M Ghuysen
December 1982, The Biochemical journal,
J Lamotte-Brasseur, and F Jacob-Dubuisson, and G Dive, and J M Frère, and J M Ghuysen
February 1973, Antimicrobial agents and chemotherapy,
J Lamotte-Brasseur, and F Jacob-Dubuisson, and G Dive, and J M Frère, and J M Ghuysen
March 2006, The Journal of biological chemistry,
Copied contents to your clipboard!